EFFICACY OF IBANDRONATE ON BONE PAIN IN POSTMENOPAUSAL OSTEOPOROSIS

被引：0
|
作者：
Marinchev, L. [1 ]
Nestorova, R. [2 ]
Rashkov, R. [1 ]
Kolarov, Z. [1 ]
机构：
[1] Univ Hosp, Clin Rheumatol, Sofia, Bulgaria
[2] Ctr Rheumatol St Irina, Sofia, Bulgaria
来源：
OSTEOPOROSIS INTERNATIONAL | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S754 / S754
页数：1
相关论文
共 50 条
  • [21] Systematic review: Ibandronate sodium for postmenopausal osteoporosis
    Wang, Qin
    Chen, Decai
    Lu, Chunyan
    Gong, Xiaoyuan
    [J]. BONE, 2008, 43 : S69 - S69
  • [22] Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone loss
    McClung, Michael R.
    Bolognese, Michael A.
    Sedarati, Farhad
    Recker, Robert R.
    Miller, Paul D.
    [J]. BONE, 2009, 44 (03) : 418 - 422
  • [23] EFFICACY OF ONCE-MONTHLY ORAL BISPHOSPHONATES (IBANDRONATE AND RISEDRONATE) IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
    Epstein, S.
    McCloskey, E.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 146 - 146
  • [24] Long-term efficacy, safety, and patient acceptability of ibandronate in the treatment of postmenopausal osteoporosis
    Inderjeeth, Charles A.
    Glendenning, Paul
    Ratnagobal, Shoba
    Inderjeeth, Diren Che
    Ondhia, Chandni
    [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2015, 7 : 7 - 17
  • [25] FEATURES OF CHANGES IN BONE REMODELING BY THE COMBINED USE OF IBANDRONATE AND ALFACALCIDOL AT THE PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS
    Rodionova, Svetlana
    Elovoy-Vronskiy, Aleksey
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S140 - S141
  • [26] Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis
    McClung, MR
    Wasnich, RD
    Recker, R
    Cauley, JA
    Chesnut, CH
    Ensrud, KE
    Burdeska, A
    Mills, T
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (01) : 11 - 18
  • [27] Daily oral ibandronate prevents bone loss in postmenopausal women without osteoporosis.
    McClung, M
    Wasnich, RD
    Recker, R
    Cauley, JA
    Ensrud, K
    Burdeska, A
    Mahoney, P
    Hughes, C
    Chesnut, C
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S157 - S157
  • [28] Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis
    Recker, R
    Stakkestad, JA
    Chesnut, CH
    Christiansen, C
    Skag, A
    Hoiseth, A
    Ettinger, M
    Mahoney, P
    Schimmer, RC
    Delmas, DP
    [J]. BONE, 2004, 34 (05) : 890 - 899
  • [29] Clinical utility of a pharmacostatistical model for ibandronate in postmenopausal osteoporosis
    Reginster, J. -Y.
    Gieschke, R.
    [J]. CURRENT DRUG METABOLISM, 2006, 7 (07) : 827 - 836
  • [30] Ibandronate: A potent new bisphosphonate in the management of postmenopausal osteoporosis
    Papapoulos, SE
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2003, 57 (05) : 417 - 422
12345